ClinicalTrials.Veeva

Menu

Natural History Study of Retinitis Pigmentosa Type 11 (ReSa)

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Active, not recruiting

Conditions

Retinitis Pigmentosa
Retinitis Pigmentosa 11

Treatments

Diagnostic Test: Clinical examinations

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Observational study of patients with retinitis pigmentosa type 11

Full description

Natural history study with clinical examination every 6 months.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of retinitis pigmentosa caused by a disease-causing mutation involving the PRPF31 gene
  • Or disease-causing mutation involving the PRPF31 gene without the clinical diagnosis of retinitis pigmentosa

Exclusion criteria

  • Under 18 years
  • Other types of retinitis pigmentosa

Trial contacts and locations

1

Loading...

Central trial contact

Josephine P Holtan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems